MEHCQ: 23andMe Holding Co. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) 70.22
Book Value / Share 3.56
Price / Book n/a
NCAV ($M) -45.62
NCAV / Share -2.31
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -2.93
Return on Assets (ROA) -0.97
Return on Equity (ROE) -2.03

Liquidity (mrq)
Quick Ratio 0.96
Current Ratio 1.11

Balance Sheet (mrq) ($M)
Current Assets 161.58
Assets 277.42
Liabilities 207.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-01 13D/A Zentree Investments Ltd 18.20 13.85
03-11 13D/A ABeeC 2.0, LLC 21.90 0.00
11-15 13D/A Glaxosmithkline Plc 9.50 -95.00
10-21 13G/A Sc Us (ttgp), Ltd. 3.90 -95.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
MDCLF – MedinCell S.A. MDIN – MedGen, Inc.
MDRM – Modern Mobility Aids, Inc. MEOBF – Mesoblast Limited
MITPF – Mithra Pharmaceuticals SA


Financial data and stock pages provided by
Fintel.io